View the latest Conatus Pharmaceuticals Inc. (CNAT) stock price, news, historical charts, analyst ratings and financial information from WSJ. CNAT | Conatus Pharmaceuticals Inc. Analyst Estimates ... Nov 06, 2019 · Conatus Pharmaceuticals Inc. analyst estimates by MarketWatch. View CNAT revenue estimates and earnings estimates, as well as analyst recommendations. CNAT Stock Price and Chart — NASDAQ:CNAT — TradingView Disclaimer: All biotechs are extremely risky, so do your own DD I like this setup in CNAT. Despite the fact CNAT has recently failed a trial, I look at this as an opportunity to run before the next dataset in the 1st half of 2019. Reasons I believe this is: Stock has a history of filling all gaps in the chart. Gap at 4.50 currently needs to be CNAT Stock | CONATUS PHARMACEUTICALS Stock Price Today ... CNAT: Get the latest Conatus Pharmaceuticals stock price and detailed information including CNAT news, historical charts and realtime prices.
CNAT:NASDAQ CM Stock Quote - Conatus Pharmaceuticals Inc ...
The falling stock market sent the Dow and S&P 500 to their worst levels of the year, and warnings from these and other stocks played a big role in the overall declines. SodaStream plunged 26% CNAT Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Conatus... (CNAT) Stock Quote | Price Chart | Volume Chart View a financial market summary for CNAT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CNAT (Conatus Pharmaceuticals Inc.) stock. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Analyst ... Based on analysts offering 12 month price targets for CNAT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
Conatus Pharmaceuticals Inc. Research & Ratings (CNAT ...
Learn about CNAT with our data and independent analysis including price, star rating, valuation, dividends, and Stocks by Morningstar Classification marsuculix (37.23) Submitted: 12/20/2016 1:56:02 AM : Outperform Start Price: $5.07 NASDAQ:CNAT Score: -108.72. now collaboration with Novartis for NASH Stable Share Price: CNAT's share price has been volatile over the past 3 months. CNAT, NasdaqCM (Nasdaq Capital Market), Yes, Common Stock, US, USD 9 Mar 2020 Given the most recent momentum in the market in the price movement of CNAT stock, some strong opinions on the matter of investing in the 3 Mar 2020 H.C. Wainwright seems to be going bullish on the price of CNAT Set to affect the volatility of a given stock, the average volume can also be a Conatus Pharmaceutic. CNAT. Delayed Nasdaq - 03/06 04:00:00 pm. 0.391USD. -7.78%. Prev. 0.2739. Open, 0.2700. High, 0.2900. Low, 0.2700. Volume, 406 11 Mar 2020 NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today risks related to the market price of Conatus' common stock relative to
Apr 03, 2020 · Stock quote and company snapshot for CONATUS PHARMACEUTICALS INC (CNAT), including profile, stock chart, recent news and events, analyst opinions, and research reports.
CNAT Conatus Pharmaceuticals Inc. — Stock Price and ... Real-time trade and investing ideas on Conatus Pharmaceuticals Inc. CNAT from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Conatus Pharmaceuticals Inc. - CNAT - Stock Price Today ... View Conatus Pharmaceuticals Inc. CNAT investment & stock information. Get the latest Conatus Pharmaceuticals Inc. CNAT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CNAT: Conatus Pharmaceuticals Inc - Stock Price, Quote and ... Get Conatus Pharmaceuticals Inc (CNAT:NASDAQ) real-time stock quotes, news and financial information from CNBC.
30 Jan 2020 traded on Nasdaq since 2013 and at one point reached a stock price ticker symbol 'CNAT'; there is expected to be a different ticker symbol
CNAT - Conatus Pharmaceutic Stock Price - Barchart.com Conatus Pharmaceutic (CNAT) Conatus Pharmaceutic (CNAT) [[ item.lastPrice ]] It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Conatus Pharmaceuticals Stock Quote: CNAT Stock News ... Nov 04, 2019 · CNAT, Conatus Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Conatus Pharmaceuticals Stock Quote: CNAT Stock News, Quotes, Analysis | Investors.com CNAT:NASDAQ CM Stock Quote - Conatus Pharmaceuticals Inc ...
Learn about CNAT with our data and independent analysis including price, star rating, valuation, dividends, and Stocks by Morningstar Classification marsuculix (37.23) Submitted: 12/20/2016 1:56:02 AM : Outperform Start Price: $5.07 NASDAQ:CNAT Score: -108.72. now collaboration with Novartis for NASH Stable Share Price: CNAT's share price has been volatile over the past 3 months. CNAT, NasdaqCM (Nasdaq Capital Market), Yes, Common Stock, US, USD 9 Mar 2020 Given the most recent momentum in the market in the price movement of CNAT stock, some strong opinions on the matter of investing in the